9 results on '"Goran, Krnjak"'
Search Results
2. Genotype–phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder
- Author
-
D’Onofrio, Gianluca, primary, Accogli, Andrea, additional, Severino, Mariasavina, additional, Caliskan, Haluk, additional, Kokotović, Tomislav, additional, Blazekovic, Antonela, additional, Jercic, Kristina Gotovac, additional, Markovic, Silvana, additional, Zigman, Tamara, additional, Goran, Krnjak, additional, Barišić, Nina, additional, Duranovic, Vlasta, additional, Ban, Ana, additional, Borovecki, Fran, additional, Ramadža, Danijela Petković, additional, Barić, Ivo, additional, Fazeli, Walid, additional, Herkenrath, Peter, additional, Marini, Carla, additional, Vittorini, Roberta, additional, Gowda, Vykuntaraju, additional, Bouman, Arjan, additional, Rocca, Clarissa, additional, Alkhawaja, Issam Azmi, additional, Murtaza, Bibi Nazia, additional, Rehman, Malik Mujaddad Ur, additional, Al Alam, Chadi, additional, Nader, Gisele, additional, Mancardi, Maria Margherita, additional, Giacomini, Thea, additional, Srivastava, Siddharth, additional, Alvi, Javeria Raza, additional, Tomoum, Hoda, additional, Matricardi, Sara, additional, Iacomino, Michele, additional, Riva, Antonella, additional, Scala, Marcello, additional, Madia, Francesca, additional, Pistorio, Angela, additional, Salpietro, Vincenzo, additional, Minetti, Carlo, additional, Rivière, Jean-Baptiste, additional, Srour, Myriam, additional, Efthymiou, Stephanie, additional, Maroofian, Reza, additional, Houlden, Henry, additional, Vernes, Sonja Catherine, additional, Zara, Federico, additional, Striano, Pasquale, additional, and Nagy, Vanja, additional
- Published
- 2023
- Full Text
- View/download PDF
3. Genotype–phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder
- Author
-
D’Onofrio, Gianluca, Accogli, Andrea, Severino, Mariasavina, Caliskan, Haluk, Kokotović, Tomislav, Blazekovic, Antonela, Jercic, Kristina Gotovac, Markovic, Silvana, Zigman, Tamara, Goran, Krnjak, Barišić, Nina, Duranovic, Vlasta, Ban, Ana, Borovecki, Fran, Ramadža, Danijela Petković, Barić, Ivo, Fazeli, Walid, Herkenrath, Peter, Marini, Carla, Vittorini, Roberta, Gowda, Vykuntaraju, Bouman, Arjan, Rocca, Clarissa, Alkhawaja, Issam Azmi, Murtaza, Bibi Nazia, Rehman, Malik Mujaddad Ur, Al Alam, Chadi, Nader, Gisele, Mancardi, Maria Margherita, Giacomini, Thea, Srivastava, Siddharth, Alvi, Javeria Raza, Tomoum, Hoda, Matricardi, Sara, Iacomino, Michele, Riva, Antonella, Scala, Marcello, Madia, Francesca, Pistorio, Angela, Salpietro, Vincenzo, Minetti, Carlo, Rivière, Jean Baptiste, Srour, Myriam, Efthymiou, Stephanie, Maroofian, Reza, Houlden, Henry, Vernes, Sonja Catherine, Zara, Federico, Striano, Pasquale, Nagy, Vanja, D’Onofrio, Gianluca, Accogli, Andrea, Severino, Mariasavina, Caliskan, Haluk, Kokotović, Tomislav, Blazekovic, Antonela, Jercic, Kristina Gotovac, Markovic, Silvana, Zigman, Tamara, Goran, Krnjak, Barišić, Nina, Duranovic, Vlasta, Ban, Ana, Borovecki, Fran, Ramadža, Danijela Petković, Barić, Ivo, Fazeli, Walid, Herkenrath, Peter, Marini, Carla, Vittorini, Roberta, Gowda, Vykuntaraju, Bouman, Arjan, Rocca, Clarissa, Alkhawaja, Issam Azmi, Murtaza, Bibi Nazia, Rehman, Malik Mujaddad Ur, Al Alam, Chadi, Nader, Gisele, Mancardi, Maria Margherita, Giacomini, Thea, Srivastava, Siddharth, Alvi, Javeria Raza, Tomoum, Hoda, Matricardi, Sara, Iacomino, Michele, Riva, Antonella, Scala, Marcello, Madia, Francesca, Pistorio, Angela, Salpietro, Vincenzo, Minetti, Carlo, Rivière, Jean Baptiste, Srour, Myriam, Efthymiou, Stephanie, Maroofian, Reza, Houlden, Henry, Vernes, Sonja Catherine, Zara, Federico, Striano, Pasquale, and Nagy, Vanja
- Abstract
Contactin-associated protein-like 2 (CNTNAP2) gene encodes for CASPR2, a presynaptic type 1 transmembrane protein, involved in cell–cell adhesion and synaptic interactions. Biallelic CNTNAP2 loss has been associated with “Pitt-Hopkins-like syndrome-1” (MIM#610042), while the pathogenic role of heterozygous variants remains controversial. We report 22 novel patients harboring mono- (n = 2) and bi-allelic (n = 20) CNTNAP2 variants and carried out a literature review to characterize the genotype–phenotype correlation. Patients (M:F 14:8) were aged between 3 and 19 years and affected by global developmental delay (GDD) (n = 21), moderate to profound intellectual disability (n = 17) and epilepsy (n = 21). Seizures mainly started in the first two years of life (median 22.5 months). Antiseizure medications were successful in controlling the seizures in about two-thirds of the patients. Autism spectrum disorder (ASD) and/or other neuropsychiatric comorbidities were present in nine patients (40.9%). Nonspecific midline brain anomalies were noted in most patients while focal signal abnormalities in the temporal lobes were noted in three subjects. Genotype–phenotype correlation was performed by also including 50 previously published patients (15 mono- and 35 bi-allelic variants). Overall, GDD (p < 0.0001), epilepsy (p < 0.0001), hyporeflexia (p = 0.012), ASD (p = 0.009), language impairment (p = 0.020) and severe cognitive impairment (p = 0.031) were significantly associated with the presence of biallelic versus monoallelic variants. We have defined the main features associated with biallelic CNTNAP2 variants, as severe cognitive impairment, epilepsy and behavioral abnormalities. We propose CASPR2-deficiency neurodevelopmental disorder as an exclusively recessive disease while the contribution of heterozygous variants is less likely to follow an autosomal dominant inheritance pattern.
- Published
- 2023
4. Genotype–phenotype correlation in contactin-associated protein-like 2 (CNTNAP-2) developmental disorder.
- Author
-
D'Onofrio, Gianluca, Accogli, Andrea, Severino, Mariasavina, Caliskan, Haluk, Kokotović, Tomislav, Blazekovic, Antonela, Jercic, Kristina Gotovac, Markovic, Silvana, Zigman, Tamara, Goran, Krnjak, Barišić, Nina, Duranovic, Vlasta, Ban, Ana, Borovecki, Fran, Ramadža, Danijela Petković, Barić, Ivo, Fazeli, Walid, Herkenrath, Peter, Marini, Carla, and Vittorini, Roberta
- Subjects
CELL adhesion ,LITERATURE reviews ,AUTISM spectrum disorders ,GENETIC variation ,MEMBRANE proteins ,DEVELOPMENTAL delay - Abstract
Contactin-associated protein-like 2 (CNTNAP2) gene encodes for CASPR2, a presynaptic type 1 transmembrane protein, involved in cell–cell adhesion and synaptic interactions. Biallelic CNTNAP2 loss has been associated with "Pitt-Hopkins-like syndrome-1" (MIM#610042), while the pathogenic role of heterozygous variants remains controversial. We report 22 novel patients harboring mono- (n = 2) and bi-allelic (n = 20) CNTNAP2 variants and carried out a literature review to characterize the genotype–phenotype correlation. Patients (M:F 14:8) were aged between 3 and 19 years and affected by global developmental delay (GDD) (n = 21), moderate to profound intellectual disability (n = 17) and epilepsy (n = 21). Seizures mainly started in the first two years of life (median 22.5 months). Antiseizure medications were successful in controlling the seizures in about two-thirds of the patients. Autism spectrum disorder (ASD) and/or other neuropsychiatric comorbidities were present in nine patients (40.9%). Nonspecific midline brain anomalies were noted in most patients while focal signal abnormalities in the temporal lobes were noted in three subjects. Genotype–phenotype correlation was performed by also including 50 previously published patients (15 mono- and 35 bi-allelic variants). Overall, GDD (p < 0.0001), epilepsy (p < 0.0001), hyporeflexia (p = 0.012), ASD (p = 0.009), language impairment (p = 0.020) and severe cognitive impairment (p = 0.031) were significantly associated with the presence of biallelic versus monoallelic variants. We have defined the main features associated with biallelic CNTNAP2 variants, as severe cognitive impairment, epilepsy and behavioral abnormalities. We propose CASPR2-deficiency neurodevelopmental disorder as an exclusively recessive disease while the contribution of heterozygous variants is less likely to follow an autosomal dominant inheritance pattern. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. A case of macrophagic myofasciitis in a girl with developmental delay
- Author
-
Goran Krnjak, Katarina Vulin, Leo Pazanin, Ingeborg Barisic, and Vlasta Duranovic
- Subjects
Myositis ,Developmental Disabilities ,Pediatrics, Perinatology and Child Health ,Humans ,Female ,Fasciitis ,aluminum, developmental disability, macrophagic myofasciitis, vaccine - Abstract
Macrophagic myofasciitis (MMF) is a localized inflammatorymyopathy characterized by infiltration of epimysium, perimy-sium, and endomysium by periodic acid-Schiff stain (PAS)positive macrophages, which contain ultrastructural cytoplas-mic aluminum inclusions.1, 2It is considered to be a localizedimmunological reaction to aluminum used as an adjuvant incertain vaccines.2Macrophagic myofasciitis was firstdescribed in France in 1998, in adult patients with systemicsymptoms such as asthenia, diffuse myalgia, and arthralgia.1In pediatric patients, MMF was described later and in fewercases than in adults, mostly in children in the first few yearsof life, with developmental delay, hypotonia, hyper-CK-emia, lactacidemia, epilepsy, and so forth. There seems to be geneticsusceptibility for developing MMF following vaccination.3While MMF is considered to cause systemic symptoms inadults, 2the clinical presentation of MMF in pediatric patients, if any, remains unclear
- Published
- 2022
6. 101 Inherited autoinflammatory encephalopathy in the differential diagnosis of conatal viral infections- newborn with Aicardi-Goutières syndrome
- Author
-
Tea Škorić, Goran Krnjak, Nina Barišić, Dora Bulić, Goran Tešović, Ivo Barić, Tamara Žigman, and Danijela Petković Ramadža
- Subjects
Pediatrics ,medicine.medical_specialty ,business.industry ,Encephalopathy ,medicine ,Aicardi–Goutières syndrome ,Differential diagnosis ,medicine.disease ,business - Published
- 2021
7. 104 Hypoketotic hypoglycemia and hyperammonemia as presenting features of early onset multiple acyl-CoA dehydrogenase deficiency
- Author
-
Dorotea Ninković, Iva Bilandžija Kuš, Ruža Grizelj, Ivo Barić, Goran Krnjak, Tamara Žigman, Ana Škaričić, Dorotea Bartoniček, Ksenija Fumić, Boris Filipović-Grčić, Nikola Mesarić, Vanja Ille, and Danijela Petković Ramadža
- Subjects
medicine.medical_specialty ,Endocrinology ,business.industry ,Internal medicine ,Hypoketotic hypoglycemia ,medicine ,Hyperammonemia ,Multiple Acyl-CoA Dehydrogenase Deficiency ,medicine.disease ,business ,Early onset - Published
- 2021
8. Expanding the known phenotype of Mullegama–Klein–Martinez syndrome in male patients
- Author
-
Goran Krnjak, Vanja Nagy, Sanda Huljev Frković, Fiona Freyberger, and Tomislav Kokotović
- Subjects
Genetics ,business.industry ,Neurodevelopmental disorders ,QH426-470 ,Biochemistry ,Phenotype ,Life ,Male patient ,QH501-531 ,cohesin ,genomic DNA ,lamotrigine ,stromal antigen 2 ,unclassified drug ,Mutation (genetic algorithm) ,Data Report ,Medicine ,Missense mutation ,business ,Clinical phenotype ,Molecular Biology ,Neurological disorders ,Rare disease - Abstract
Here, we report a novel case of a male patient with a hemizygous missense variant in STAG2 (p.Tyr159His) resulting in Mullegama–Klein–Martinez syndrome (MKMS), a rare X-linked cohesinopathy. He shares distinct clinical features with a previously reported male patient carrying the STAG2 variant p.Tyr159Cys, suggesting that this phenotype is determined by the position of the mutation. Additionally, our patient exhibits symptoms not previously associated with MKMS, expanding the known clinical phenotype of this rare disease.
- Published
- 2021
9. Urolithiasis – a potential complication of ceftriaxone therapy
- Author
-
Branko Miše, Danica Batinić, Marija Spajić, Danko Milosevic, Goran Krnjak, Daniel Turudić, and Ivan Habuš
- Subjects
Physics ,Pediatrics, Perinatology and Child Health ,Humanities - Abstract
Svrha studije je bila procijeniti rizik nastanka urolitijaze u djece lijecene ceftriaksonom. Retrospektivno je analizirano 238-ero djece s cistopijelonefritisom, lijecene u 2011. godini, ceftriaksonom u standardnoj dozi od 60 mg/kg/dan kroz 10 dana. Slikovnom obradom u 74-ero djece nađene su anomalije mokracnog sustava, od cega u njih 66-ero vezikoureteralni refluks, a u 7- ero hidronefroza. Ni u jednog djeteta nije nađena urolitijaza. Klinickim pracenjem kroz mjesec dana nije bilo klinickih i/ili laboratorijskih indirektnih znakova urolitijaze. Može se zakljuciti da je lijecenje ceftriaksonom u standardnoj dozi i dužini trajanja sigurno. Oprez je nužan ako su potrebne vise doze i/ili produženo davanje. U tom slucaju preporucujemo pregled mokracnog sustava i žucnjaka, probir na hiperkalciuriju i alkalinizaciju urina.
- Published
- 2014
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.